Beranda › Glioblastoma › North Carolina › Durham
Uji klinis Glioblastoma di Durham, NC
20 studi untuk Glioblastoma mencari peserta di lokasi sekitar Durham (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
Menerima pesertaFase 3
- University of North Carolina, Chapel Hill · 10 mi jauhnya
Targeted Pediatric High-Grade Glioma Therapy
Menerima pesertaStudi observasional
- Duke University Health System, Durham
Study of Olutasidenib and Temozolomide in HGG
Menerima pesertaFase 2
- Duke University Health System, Durham
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Menerima pesertaFase 3
- Duke Cancer Institute, Durham
BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma
Menerima pesertaFase 1
- Duke University Medical Center, Durham
Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
Menerima pesertaFase 2
- Duke University Medical Center, Durham
A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment
Menerima pesertaFase 2
- Duke University, Durham
A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial
Menerima pesertaFase 2
- Duke University, Durham
Lerapolturev (PVSRIPO) in GBM
Menerima pesertaFase 2
- Duke University Medical Center, Durham
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
Menerima pesertaFase 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauhnya
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Menerima pesertaFase awal 1Sukarelawan sehat diterima
- Duke University Health System, Durham
Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma
Menerima pesertaFase 1
- Duke University Medical Center, Durham
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Menerima pesertaFase 2
- Duke University Health System, Durham
Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
Menerima pesertaFase 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauhnya
Key Longitudinal Associations With Risk and Glioblastoma Outcomes
Menerima pesertaStudi observasional
- Duke University, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi jauhnya
D2C7-IT + 2141-V11 Combination Post-resection in rGBM
Menerima pesertaFase 1
- Duke University Medical Center, Durham
D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients
Menerima pesertaFase 1/2
- Duke University Medical Center, Durham
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Menerima pesertaFase 2
- University of North Carolina, Chapel Hill · 10 mi jauhnya
Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
Menerima pesertaFase 1
- Duke University, Durham
Uji klinis Glioblastoma di kota lain
- New York City, NY30 studi
- Boston, MA28 studi
- Houston, TX26 studi
- Los Angeles, CA24 studi
- San Francisco, CA17 studi
- Chicago, IL15 studi
- Washington, DC15 studi
- Columbus, OH14 studi
- Miami, FL14 studi
- Rochester, MN13 studi
- Jacksonville, FL13 studi
- Aurora, CO12 studi
Studi lain di Durham
- Kanker Payudara64 studi
- Kanker (semua jenis)58 studi
- Kanker Paru Non-Sel Kecil39 studi
- Mieloma Multipel37 studi
- Leukemia Mieloid Akut33 studi
- Kanker Metastatik33 studi
- Kanker Prostat32 studi
- Kanker Paru32 studi
- Kanker Kolorektal28 studi
- Kanker Ovarium27 studi
- Leukemia Limfositik Kronis27 studi
- Gagal Jantung26 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.